Arlo insider files Form 144 after multi-block 10b5-1 sales totaling hundreds of thousands

Rhea-AI Filing Summary

Arlo Technologies, Inc. (ARLO) notice reports a proposed sale of 68,560 common shares through Morgan Stanley Smith Barney on 09/30/2025 with an aggregate market value of $1,175,118.40. The filing lists 104,370,654 shares outstanding. The securities to be sold were acquired as 33,051 performance stock units on 03/17/2025 and 35,509 restricted stock units on 09/26/2025. The filing also discloses multiple prior sales by Kurtis Binder in the past three months, including 125,000 shares on 09/02/2025 under a 10b5-1 plan and other 10b5-1 or direct sales totaling several hundred thousand shares and gross proceeds in the millions. The signer affirms they are not aware of undisclosed material adverse information and, where applicable, indicates reliance on Rule 10b5-1 trading plans.

Positive

• Planned sale disclosed with broker details, providing market transparency about the intended transaction
• Source of shares identified as performance stock units and restricted stock units granted in 2025, clarifying origination
• Use of 10b5-1 plans for prior sales is disclosed, indicating some sales were prearranged and not opportunistic

Negative

• Substantial insider selling in recent months (e.g., 125,000; 113,912; 92,247; 81,440 shares) which increased share supply from insiders
• Material proceeds in prior sales total several million dollars, which could be perceived negatively by some investors

Insights

Securities Analyst

TL;DR: Insider proposes a controlled sale of 68,560 shares and has executed substantial 10b5-1 and other sales recently, totaling several hundred thousand shares.

The filing documents a planned sale executed through Morgan Stanley and identifies the source of shares as PSU and RSU awards granted in 2025. Prior sales by Kurtis Binder include multiple large blocks (125,000; 113,912; 92,247; 81,440) generating multi-million-dollar proceeds, with at least some executed under 10b5-1 plans. For investors, such concentrated insider selling increases share supply from insiders and may be relevant when evaluating near-term share pressure or insider liquidity, though the filing does not state motivations or any undisclosed material information.

Corporate Governance Expert

TL;DR: The disclosure appears procedurally complete, citing 10b5-1 plans and the standard nonpublic information representation.

The form provides required particulars: broker, share counts, acquisition dates, types of awards, and recent sales history by the named insider. The inclusion of 10b5-1 sales indicates pre-planned dispositions which helps mitigate concerns about opportunistic insider trading; however, the filing does not include the plan adoption dates in the visible fields, which are often provided to establish compliance timing. The signer’s attestation about lack of material nonpublic information is present, consistent with Rule 144 requirements.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	68560	1175118.40	104370654	09/30/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/17/2025	Performance Stock Units	Issuer			33051	03/17/2025	N/A
Common	09/26/2025	Restricted Stock Units	Issuer			35509	09/26/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
KURTIS BINDER 5770 Fleet Street Carlsbad CA 92008	Common	09/29/2025	81440	1388071.50
10b5-1 Sales for KURTIS BINDER 5770 Fleet Street Carlsbad CA 92008	Common	09/02/2025	125000	2214051.34
10b5-1 Sales for KURTIS BINDER 5770 Fleet Street Carlsbad CA 92008	Common	08/08/2025	113912	2113978.90
10b5-1 Sales for KURTIS BINDER 5770 Fleet Street Carlsbad CA 92008	Common	07/01/2025	92247	1583613.47

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What share amount is ARLO proposing to sell under this Form 144?

The notice covers a proposed sale of 68,560 common shares to be sold through Morgan Stanley Smith Barney on 09/30/2025.

What is the aggregate market value of the shares proposed for sale in this filing?

The aggregate market value reported for the proposed sale is $1,175,118.40.

What was the source and acquisition dates of the securities to be sold?

The securities were acquired as 33,051 performance stock units on 03/17/2025 and 35,509 restricted stock units on 09/26/2025.

Has the filer sold ARLO shares recently and in what amounts?

Yes. The filing discloses recent sales by Kurtis Binder including 125,000 shares on 09/02/2025 (10b5-1), 113,912 on 08/08/2025, 92,247 on 07/01/2025, and 81,440 on 09/29/2025, with gross proceeds in the millions.

Does the filing state whether the seller knows of any undisclosed material information?

Yes. By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.